# everlinQ Endovascular Access Systems Enhancements (EASE-2) Study

> **NCT03708562** · NA · COMPLETED · sponsor: **C. R. Bard** · enrollment: 24 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DEVICE:** everlinQ endoAVF System

## Key facts

- **NCT ID:** NCT03708562
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-16
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03708562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03708562, "everlinQ Endovascular Access Systems Enhancements (EASE-2) Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03708562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*